The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

Diabetes affects millions worldwide, often triggering complications such as insulin resistance and fatty liver disease. To ...

A team of scientists has found new clues that could change how we think about aging. Their work suggests that aging might not ...

New findings reveal a chilling link between type 2 diabetes and a hidden danger. The truth could change how we see both ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.

Biomedical engineer Joshua Doloff uses federal funding to pioneer immunotherapies that could free diabetes patients from ...

Alongside this research, other studies have shown that lifestyle choices can also help manage diabetes. Eating more whole ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

Broad access to new obesity drugs leads to longer, healthier lives, delivering a substantial societal return on investment, ...

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic ...

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.